30 closest matches · ranked by relevance
Fever
Primary: Number of Participants With Admission to Hospital Due to Parental High Levels of Worry — 87 Participants
Children Who Present to the ED With Minor Febrile Illnesses
Primary: Recidivism — 6; 3 number of return visits within 72 ho
Fever Without Source
Primary: Antibiotic Prescription Rate — 54; 59 participants — p=1
Fever · Infection · Inflammation
Primary: Number of Participants With Clinically-assigned Retrospective Phenotype — 655; 0 Participants
Influenza · Otitis Media · Lower Resp Tract Infection
Primary: Hospitalization — 26; 2 Participants
Pain · Fever
Primary: Number of Participants Reporting Safe Dosing at 48-72 Hours — 28; 25 Participants
Fever After Vaccination · Fever · Febrile Seizure
Primary: Number of Participants With Fever Following Vaccination — 8; 10 Participants — p=0.7588
Acute Febrile Illness
Primary: The Etiologies (Bacteria, Viruses, Parasites, Fungi and Others) of Fever Illness Expressed in Percentages of Enrolled Subjects. — 621; 362; 15; 5 Participants
Influenza
Primary: Number of Subjects With Laboratory-confirmed Influenza Presenting With an Acute Respiratory Illness (ARI) and/or Isolated Fever — 120; 11 Participants
Diarrhea Bloody
Primary: Blood Test Performance — 18; 17 Participants
Fever
Primary: Fever >= 100.4 — 7.5; 37.6; 9.5 percentage of participants
Hospitalization · Child Health
Primary: Timeliness of Clinical Care - Initial Therapeutic Management — 142; 153 minutes — p=<0.001
Asthma
Primary: Symptom Days — 6.24; 4.82 symptom days over past 14 days — p=0.06
Asthma · Wheezing
Primary: Exacerbation Frequency — 0.81; .87 asthma exacerbations per 46 weeks — p=0.67
Asthma in Children
Primary: Proportion of Patients Admitted to the Hospital in Each Group — 6; 15 Participants
Pneumonia · Pediatric Respiratory Diseases · Antibiotic Use
Primary: Total Pilot Trial Enrollment — 0; 1 Participants
Penicillin Allergy · Pediatric Emergency Medicine
Primary: Number of Oral Amoxicillin Challenge Participants Completing Challenge With Insignificant Adverse Result — 114; 2 Participants
Asthma
Primary: Number of Symptom-Free Days in the Prior 2 Weeks — 9.5; 10.1 days
Emergencies
Primary: Triage Time — 126.7; 94.4 Seconds — p=<0.0005
Appendicitis
Primary: Pre to Post Ratio of Image Use — 1.13; 1.07; 1.03; 1.01 ratio of pre-post use
Fever
Primary: Child Temperature (Degrees C)Over 6 Hours — 38.5; 37.2; 36.9 degrees Celcius — p=<0.001
Febrile Illness
Primary: Proportion of Survival With Symptom Resolution — 96.9 percentage of participants
Concussion · Headache
Primary: Number of Headache Days — 4; 3; 3; 4 number of headache days
Acute Urinary Tract Infection · Urinary Tract Infection
Primary: The Distribution of Children With Renal Scarring at the Outcome Dimercaptosuccinic Acid (DMSA) Renal Scan — 12; 22; 111; 109 Participants — p=0.16
Childhood Obesity
Primary: Diagnosis of Infectious Disease — 900; 1067 Participants — p=.026
Influenza
Primary: Percentage of Participants With Fever (Fever Rate) Following Vaccination With Fluzone Quadrivalent Vaccine — 11.31; 12.15 percentage of participants
Asthma
Primary: Change in Pulmonary Asthma Score (PAS) — 0.9; 0.4 mean PAS score
Asthma
Primary: Number of Inhaled Corticosteroid (ICS) Prescriptions Refilled (Confirmed by Primary Care Physician) — 18; 32 Participants — p=0.87
Pneumonia Childhood
Primary: Inappropriate Disposition — 7; 6 Participants
Bronchiolitis
Primary: Parental Anxiety — 4.2; 3.9 points on a scale